Phase-change nanoparticle
First Claim
1. Apparatus for use with a subject suffering from cancer, a body of the subject containing cancerous cells and non-cancerous cells, and for use with a heating device configured to heat at least a portion of the subject'"'"'s body, the apparatus comprising:
- a nanoparticle comprising;
an inner core that comprises a phase-change material that is configured to absorb latent heat of fusion by undergoing a phase change selected from the group consisting of;
solid to liquid, and gel to liquid, the phase-change occurring at a phase-change temperature of between 42°
C. and 80°
C.;
an outer layer disposed around the inner core, the outer layer comprising;
a plurality of nano-spheres of at least one metal; and
a plurality of molecules of a substance that binds preferentially with cancerous cells relative to non-cancerous cells,the nanoparticle having a volume of at least 65,000 nm3,the nanoparticle being elongatable into an ellipsoid, such that when the nanoparticle is maximally elongated;
each of the semi-axes defined by the ellipsoid is greater than 5 nm, andat least two of the semi axes of the ellipsoid are less than 30 nm.
1 Assignment
0 Petitions
Accused Products
Abstract
Apparatus and methods are described for use with a subject suffering from cancer. A nanoparticle (22) includes an inner core (30) that comprises a phase-change material that is configured to absorb latent heat of fusion by undergoing a phase change. An outer layer (32) disposed around the inner core includes a plurality of nano-spheres (34) of at least one metal, and a plurality of molecules (38) of a substance that binds preferentially with cancerous cells relative to non-cancerous cells. The nanoparticle has a volume of at least 65,000 nm3 and is elongatable into an ellipsoid, such that, when the nanoparticle is maximally elongated, each of the semi-axes defined by the ellipsoid is greater than 5 nm, and at least two of the semi axes of the ellipsoid are less than 30 nm. Other applications are also described.
-
Citations
30 Claims
-
1. Apparatus for use with a subject suffering from cancer, a body of the subject containing cancerous cells and non-cancerous cells, and for use with a heating device configured to heat at least a portion of the subject'"'"'s body, the apparatus comprising:
-
a nanoparticle comprising; an inner core that comprises a phase-change material that is configured to absorb latent heat of fusion by undergoing a phase change selected from the group consisting of;
solid to liquid, and gel to liquid, the phase-change occurring at a phase-change temperature of between 42°
C. and 80°
C.;an outer layer disposed around the inner core, the outer layer comprising; a plurality of nano-spheres of at least one metal; and a plurality of molecules of a substance that binds preferentially with cancerous cells relative to non-cancerous cells, the nanoparticle having a volume of at least 65,000 nm3, the nanoparticle being elongatable into an ellipsoid, such that when the nanoparticle is maximally elongated; each of the semi-axes defined by the ellipsoid is greater than 5 nm, and at least two of the semi axes of the ellipsoid are less than 30 nm. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. A method comprising:
-
synthesizing a nanoparticle to have a volume of at least 65,000 nm3, and to be elongatable into an ellipsoid, such that when the nanoparticle is maximally elongated; each of the semi-axes defined by the ellipsoid is greater than 5 nm, and at least two of the semi axes of the ellipsoid are less than 30 nm, the synthesizing being performed by; providing an inner core that includes a phase-change material that is configured to absorb latent heat of fusion, by undergoing a phase change selected from the group consisting of;
solid to liquid, and gel to liquid, the phase-change occurring at a phase-change temperature of between 42°
C. and 80°
C.,binding an outer layer to the inner core, the outer layer including; a plurality of nano-spheres of at least one metal, and a plurality of molecules of a substance that binds preferentially with cancerous cells relative to non-cancerous cells. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification